Quick Answer
Entera Bio Ltd. reported Total Revenue of $42.0 thousand for the year ending 2025.
- Entera Bio Ltd. showed a decrease of -76.8% in Total Revenue from 2024 to 2025.
- This data is from Entera Bio Ltd.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $157.0 thousand | Q2 2021: $109.0 thousand | Q3 2021: $140.0 thousand | Q1 2022: $68.0 thousand | Q2 2022: $44.0 thousand | Q3 2022: $8.0 thousand | Q1 2023: $0.00 | Q2 2023: $0.00 | Q3 2023: $0.00 | Q1 2024: $0.00 | Q2 2024: $57.0 thousand | Q3 2024: $42.0 thousand | Q1 2025: $42.0 thousand | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 6 years of available data (2020 to 2025), Entera Bio Ltd.'s Total Revenue has declined by 88.5%.
- Historical annual values: Fiscal year 2025: $42.0 thousand | Fiscal year 2024: $181.0 thousand | Fiscal year 2023: $0.00 | Fiscal year 2022: $134.0 thousand | Fiscal year 2021: $571.0 thousand | Fiscal year 2020: $365.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: